778 research outputs found

    Phase 1 Safety and Tolerability Study of BMP-7 in Symptomatic Knee Osteoarthritis

    Get PDF
    BACKGROUND: There are no proven therapies that modify the structural changes associated with osteoarthritis (OA). Preclinical data suggests that intra-articular recombinant human BMP-7 (bone morphogenetic protein-7) has reparative effects on cartilage, as well as on symptoms of joint pain. The objective of this study was to determine the safety and tolerability as well as dose-limiting toxicity and maximal tolerated dose of intra-articular BMP-7. The secondary objectives were to determine the effect on symptomatic responses through 24 weeks. METHODS: This was a Phase 1, double-blind, randomized, multi-center, placebo-controlled, single-dose escalation safety study consisting of 4 dosing cohorts in participants with knee OA. Each cohort was to consist of 8 treated participants, with treatment allocation in a 3:1 active (intra-articular BMP-7) to placebo ratio. Eligible participants were persons with symptomatic radiographic knee OA over the age of 40. The primary objective of this study was to determine the safety and tolerability of BMP-7 including laboratory assessments, immunogenicity data and radiographic assessments. Secondary objectives were to determine the proportion of participants with a 20%, 50%, and 70% improvement in the WOMAC pain and function subscales at 4, 8, 12, and 24 weeks. Other secondary outcomes included the change from baseline to 4, 8, 12, and 24 weeks for the OARSI responder criteria. RESULTS: The mean age of participants was 60 years and 73% were female. All 33 participants who were enrolled completed the study and most adverse events were mild or moderate and were similar in placebo and BMP-7 groups. The 1 mg BMP-7 group showed a higher frequency of injection site pain and there was no ectopic bone formation seen on plain x-rays. By week 12, most participants in both the BMP-7 and placebo groups experienced a 20% improvement in pain and overall the BMP-7 group was similar to placebo with regard to this measurement. In the participants who received 0.1 mg and 0.3 mg BMP-7, there was a trend toward greater symptomatic improvement than placebo. The other secondary endpoints showed similar trends including the OARSI responder criteria for which the BMP-7 groups had more responders than placebo. CONCLUSIONS: There was no dose limiting toxicity identified in this study. The suggestion of a symptom response, together with the lack of dose limiting toxicity provide further support for the continued development of this product for the treatment of osteoarthritis.ARC Future Fellowship; Stryker Biotec

    Quantifying the Impact of Traffic on Electric Vehicle Efficiency

    Get PDF
    While the influence of several factors on battery electric vehicle (BEV) efficiency has been investigated in the past, their impact on traffic is not yet fully understood, especially when driving in a natural environment. This paper investigates the influence of driving in intense traffic conditions while considering the ambient temperature and driving behavior on BEV energy efficiency in a field study. A total of 30 BEV inexperienced drivers test drove a 2017 Volkswagen eGolf on a route with various road types in two different traffic intensity scenarios: During morning commute hours with higher traffic congestion and lower congestion hours throughout the middle of the day. Results support the hypothesis that traffic conditions significantly impact the vehicleā€™s efficiency, with additional consumption of approximately 4ā€“5% in the high traffic scenario. By creating and comparing driving in traffic to an underlying base case scenario, the additional range potential by avoiding traffic for this particular vehicle can be quantified as up to seven miles. New patterns of BEV efficiencies emerged, which can help stakeholders understand how eco-driving can be strategically improved by selecting trip times and routes that avoid high traffic intensity

    What sort of cognitive hypothesis is a derivational theory of grammar?

    Get PDF
    This paper has two closely related aims. The main aim is to lay out one specific way in which the derivational aspects of a grammatical theory can contribute to the cognitive claims made by that theory, to demonstrate that it is not only a theoryā€™s posited representations that testable cognitive hypotheses derive from. This requires, however, an understanding of grammatical derivations that initially appears somewhat unnatural in the context of modern generative syntax. The second aim is to argue that this impression is misleading: certain accidents of the way our theories developed over the decades have led to a situation that makes it artificially difficult to apply the understanding of derivations that I adopt to modern generative grammar. Comparisons with other derivational formalisms and with earlier generative grammars serve to clarify the question of how derivational systems can, in general, constitute hypotheses about mental phenomena

    Divergence or convergence? Health inequalities and policy in a devolved Britain

    Get PDF
    Since the advent of political devolution in the UK, it has been widely reported that markedly different health policies have emerged. However, most of these analyses are based on a comparison of health care policies and, as such, only tell part of a complex and evolving story. This paper considers official responses to a shared public health policy aim, the reduction of health inequalities, through an examination of national policy statements produced in England, Scotland and Wales respectively since 1997. The analysis suggests that the relatively consistent manner in which the ā€˜policy problemā€™ of health inequalities has been framed combined with the dominance of a medical model of health have constrained policy responses. Our findings differ from existing analyses, raising some important questions about the actuality of, and scope for, policy divergence since devolution
    • ā€¦
    corecore